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Background: Histamine is an important mediator in the development of allergic reactions. The 
biological effects of histamine are mediated through four histaminergic receptors. In recent years, 
an important role has been assigned to the proinflammatory functions of histamine regarding the 
H4 receptor. Previously, we have demonstrated that injection of immature dendritic cells treated 
with histamine into allergic mice promotes an increase in CD8+ Tc2 lymphocytes, which are 
involved in the worsening of allergy symptoms during the chronic phase of the disease. The aim of 
this study was to evaluate the role of the H3/H4 receptor antagonist, thioperamide, in allergy.
Methods: Ovalbumin-allergized mice and nonallergized mice were injected with phosphate-
buffered saline, dendritic cells, or thioperamide-treated dendritic cells. After treatment, the lungs 
of the mice were obtained and analyzed for changes in the populations of dendritic cells and T 
lymphocytes, as well as the expression of H and H4 receptors in mononuclear lung cells.
Results: We found an increase in regulatory T cells in the lungs of allergic mice intratracheally 
injected with dendritic cells which had their H3/H4 receptors blocked with thioperamide. We 
also found an increase in the production of interleukin-10 by dendritic cells of the lung. Finally, 
we observed a decrease in serum levels of specific anti-IgE and a reduction of eosinophils in 
bronchoalveolar lavage from allergic mice.
Conclusion: Thioperamide induces a significant improvement in symptoms of allergic reaction 
perhaps via induction of regulatory T lymphocytes. These findings may become relevant in the 
understanding of type 1 hypersensivity reactions.
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Introduction
Dendritic cells are antigen-presenting cells with a unique ability to initiate the adap-
tive response by activating naïve T lymphocytes. However, these cells are not only 
able to prime immune responses, but also induce self-tolerance.1,2 The recognition 
of inflammatory stimuli or pathogens in the periphery imposes several changes in 
dendritic cells, leading to their maturation. These changes enable dendritic cells to 
activate T lymphocytes and to determine their profile of polarization.3,4
Histamine plays a central role in the regulation of both inflammatory and immune 
responses. It is also able to modulate the function of dendritic cells. Histamine 
stimulates the chemotaxis of immature dendritic cells and promotes differentiation 
of T CD4+ lymphocytes into a Th2 profile.5 In addition, in immature dendritic cells 
from mice, histamine induces the cross-presentation of soluble antigens, such as oval-
bumin, acting through H3/H4 receptors.6 Recently, we found a higher recruitment of 
CD11c+/CD8+ dendritic cells and Tc2 type T CD8+ cells in the lungs of allergic mice 
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receiving dendritic cells treated with histamine and pulsed 
with ovalbumin.7 In addition, these mice showed increased 
levels of serum-specific IgE antibodies and a more persistent 
presence of eosinophils in bronchoalveolar lavage compared 
with mice treated with ovalbumin-pulsed control dendritic 
cells. This suggests that histamine may influence the severity 
of allergies by acting on dendritic cells.
Allergic diseases, including conjunctivitis, allergic   rhinitis, 
asthma, and atopic dermatitis, are inflammatory   disorders 
in which susceptible individuals respond by producing 
  allergen-specific Th2 lymphocytes.8,9 Histamine is one of the 
most important mediators of allergy and inflammation. Although 
its effects are mediated via four receptors,10 signaling through 
H1R seems to play a central role in the induction of allergy, 
but the use of antagonists of this receptor, like ketotifen,11 did 
not prove to be effective in most of these pathologies because 
the symptoms did not disappear completely.12
It was shown that the H4 receptor plays an essential 
role in inflammatory pathologies. H4R was involved in the 
amplification of allergic symptoms as well as the mainte-
nance of chronic inflammation.13 In this study, we evalu-
ated the effect of injection of dendritic cells pretreated with 
thioperamide and pulsed with ovalbumin in allergic mice 
in vitro. Interestingly, we found a significant increase in 
CD4+ CD25+ FOXP3+ lymphocytes, as well as increased 
levels of interleukin-10 in lung dendritic cells of allergic 
mice. In addition, the levels of specific anti-IgE antibodies 
as the percentages of eosinophils are decreased. Therefore, 
H3/H4 receptors would be central to the induction of chronic 
inflammatory responses. Future studies may determine 
whether the use of antagonists of these receptors could offer 
an alternative in the treatment of inflammatory disorders 
through the induction of a regulatory profile.
Methods
Mice
All experiments were carried out using two-month-old virgin 
female BALB/c mice raised at the National Academy of 
Medicine, Buenos Aires, Argentina. They were housed as 
4–6 animals per cage and kept at 20°C ± 2°C on an automatic 
12-hour light-dark schedule. Animal care was in accordance 
with institutional guidelines.
Sensitization and challenge  
with ovalbumin
Mice (4–6 per experiment) were sensitized using a stan-
dard protocol, as described previously.14 Briefly, mice were 
injected intraperitoneally with 20 µg of ovalbumin (Grade V , 
Sigma-Aldrich, St Louis, MO) in 2 mg of aluminum hydrox-
ide at days 0 and 7. Control mice received a saline injection 
instead of ovalbumin/aluminum hydroxide solution (Sigma, 
St Louis, MO). On day 14, sensitized mice were challenged 
intranasally with 50 µL of phosphate-buffered saline contain-
ing 3% ovalbumin for five days. Control mice were instilled 
with phosphate-buffered saline.
Dendritic cell generation from bone 
marrow cultures
The procedure used to obtain dendritic cells was performed 
as described by Inaba et al,15 with minor modifications.16 
Briefly, bone marrow was flushed from the long bones of 
the limbs using 2 mL of RPMI 1640 medium (Invitrogen, 
Carlsbad, CA) with a syringe and 25-gauge needle. Red cells 
were lysed with ammonium chloride. After washing, the cells 
were suspended at a concentration of 1.5 × 106 cells/mL in 
70% RPMI 1640 medium supplemented with 10% fetal calf 
serum, and 5.5 × 10−5 mercaptoethanol (complete medium 
[Gibco, Buenos Aires, Argentina]) from Sigma and 30% 
J588-GM cell line supernatant. The cultures were fed every 
two days by gently swirling the plates, aspirating 50% of the 
medium, and adding back fresh medium with J588-GM cell 
line supernatant. At day 9 of the culture, more than 80% of 
the harvested cells expressed major histocompatibility class 
(MHC) II, CD40 and CD11c, but not GR-1 (not shown).
Intratracheal injection of dendritic cells
Dendritic cells obtained from bone marrow precursors were 
incubated in the absence or presence of thioperamide 100 µM 
(dendritic cells and thioperamide-pretreated dendritic cells, 
respectively) for 30 minutes at 37ºC. The cells were then 
incubated for three hours at 37ºC in the presence or absence 
of ovalbumin 100 µg/mL. Finally, the dendritic cells were 
washed and injected intratracheally into BALB/c mice after 
intranasal challenge of sensitized mice with ovalbumin. For 
this purpose, the mice were anesthetized with pentobarbital 
sodium (Nembutal, [Abbott Laboratories, Buenos Aires, 
Argentina]) (2% v/v in phosphate-buffered saline), and 100 µL 
of phosphate-buffered saline, dendritic cells, or thioperamide-
pretreated dendritic cells (5 × 105 cells) were injected.
Treatment of lung tissues to obtain  
a cellular suspension
The lungs were cut into small pieces and treated with Type I 
collagenase 250 U/mL (Roche, Buenos Aires, Argentina) for 
30 minutes at 37°C. At the end of the incubation time, the 
reaction was stopped by addition of phosphate-buffered saline 
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supplemented with 5% fetal calf serum. Subsequently, the 
fragments were incubated with DNase I 50 U/mL (Invitrogen, 
Buenos Aires, Argentina) for 40 minutes at 37°C. Finally, 
the cell suspensions were collected through a gauze mesh 
and washed with cold phosphate-buffered saline. For the 
analysis of H3 and H4 receptors, lung suspensions were 
seeded in a Ficoll-Hypaque (Amersham Biosciences, Buenos 
Aires, Argentina) gradient and centrifuged for 40 minutes at 
1600 rpm to obtain the mononuclear cell monolayer.
Bronchoalveolar lavage
At 15 or 30 days, after treatment of the allergic mice with 
phosphate-buffered saline, dendritic cells, or thioperamide-
pretreated dendritic cells, the lungs were washed via a tra-
cheal tube with phosphate-buffered saline. Cells were washed 
and leukocyte counts were determined by optical microscopy. 
Cytospin slides were stained with toluidine to determine the 
percentages of eosinophils in bronchoalveolar lavage.
Flow cytometry
Cells were stained for cell surface markers with the following 
monoclonal antibodies: anti-CD11c, anti-CD40, anti-CD86, 
anti-MHC class II, anti-CD4+, anti-CD25+, and anti-GR1 (FITC, 
PE or PERCP, Pharmingen, San Diego, CA). The staining was 
analyzed by flow cytometry on FACScan using Cellquest 
software (BD Biosciences, Buenos Aires, Argentina).
Analysis of serum levels of IgE antibodies 
directed to ovalbumin
Serum samples were obtained from the mice at the end of the 
experiments by cardiac puncture. Ovalbumin-specific IgE 
antibodies were determined using plates coated overnight 
with 1 µg/mL ovalbumin in sodium carbonate buffer (pH 9.5, 
Sigma-Aldrich, St Louis, MO). Plates were pretreated with 
Tween 0.5% in phosphate-buffered saline supplemented with 
1% bovine serum albumin for two hours at room temperature. 
Serial dilutions of sera were added and, after two hours, the 
plates were washed three times with Tween 0.5% in phosphate-
buffered saline, and an appropriate dilution of biotinylated 
detection antibody (rat anti-mouse IgE, BD Pharmingen, Bue-
nos Aires, Argentina) was added for one hour. After washing 
the plates, the enzyme avidine-peroxidase (eBiosciences) was 
added for 20 minutes. 3, 3′, 5, 5′-tetramethylbenzidine was 
used as a substrate. Absorbance was measured at 450 nm.
Cell purification
T cells and dendritic cells were purified from lung cell 
suspensions using an autoMACS separator in accordance 
with the manufacturer’s protocol (Miltenyi Biotec, Hanover, 
Germany). Dendritic cells and T cells were purified by posi-
tive selection using magnetic beads coupled to anti-CD11c+ 
and anti-CD3, respectively.
Intracellular FOXP3 staining
Purified T cells were fixed in 4% paraformaldehyde and 
permeabilized with saponin (0.1% in phosphate-buffered 
saline). The cells were then incubated with FITC-conjugated 
anti-FOXP3 in phosphate-buffered saline 0.5% bovine serum 
albumin or a similarly labeled isotype-matched control 
antibody for 30 minutes. Antibodies against FOXP3 was 
purchased from BD Pharmingen. Cells were subsequently 
washed with phosphate-buffered saline and stained for sur-
face cell markers with the monoclonal antibodies anti-CD4+ 
and anti-CD25+. The stained cells were washed with saponin 
buffer twice and resuspended in isoflow. The staining was 
analyzed by flow cytometry on FACscan using Cellquest 
software.
Interleukin-10 production
Dendritic cells purified from the lungs were stimulated for 
18 hours with ovalbumin 10 ng/mL. Interleukin-10 production 
was then analyzed by enzyme-linked immunosorbent assay 
(eBiosciense, San Diego, CA) in the supernatants of CD11c+ 
cells (1.5 × 105 cells/200 µL cultured for 18 hours).
Confocal microscopy
Mononuclear cells from lung tissue of BALB/c mice were 
used for receptor expression analysis, and were fixed with 
a mixture of 2% paraformaldehyde (Merck, Germany) and 
0.125% glutaraldehyde (Electron Microscopy Science, 
Hartfield, PA) in 0.2 M phosphate buffer at pH 7.4 for two 
hours at room temperature. Fixed cells were processed for 
ultrathin cryosectioning, immunogold-labeled and contrasted 
as described previously.17 Cells (5 × 104) were incubated for 
30 minutes at room temperature. Then cells were fixed in 
4% paraformaldehyde for 10 minutes at 4°C, after which 
the cells were treated with 0.1 M of glycine to blocked 
aldehyde groups. Cells were washed with cold medium and 
fixed as above. At the optimal antibody concentrations, no 
background labeling of the nucleus and mitochondria was 
detected (data not shown). Sections were observed and 
photographed under a Philips CM120 electron microscope 
(FEI Company,   Eindoven, The Netherlands). Images were 
acquired using the ITEM program. The quantification of 
H3 and H4 receptor expression was performed using the 
Image J program.
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T lymphocyte proliferation assay
For the autologous Ag-specific proliferation assay, 2.5 × 105 
T lymphocytes from the lungs of BALB/c mice previously 
allergized were cocultured with 5 × 104 purified dendritic cells 
from BALB/c mice that were treated in vitro with   ovalbumin. 
At 72 hours, cells were pulsed with [3H] thymidine (1 µCi/
well, DuPont-New England Biolabs, Boston, MA). Then cells 
were harvested using a semiautomatic harvester (Skatron 
Instruments), and the amount of [3H]thymidine incorporation 
was determined in a Wallac 1414 Winspectral beta scintilla-
tion counter (PerkinElmer). Unspecific T cell proliferation 
was measured by stimulation of 2.5 × 105 splenocytes with 1 
µg/mL lipopolysaccharide (Sigma-Aldrich) for 96 hours.
Statistical analysis
Statistically significant differences between means were 
assessed by the Student’s t-test. P , 0.05 was taken as indi-
cating statistical significance.
Results
Previously we have demonstrated that histamine increases 
the cross-presentation of extracellular antigens by dendritic 
cells acting through H3R/H4R.18 Moreover, we found in a 
mouse model of allergic airway inflammation that injection 
of dendritic cells treated with histamine in vitro increases 
recruitment of Tc2 CD8+ T cells in the lungs of allergic mice, 
suggesting an effect on the chronicity of the process.7 In light 
of these findings, we decided to investigate the role of H4/H3 
receptors in the development of the allergic process. Airway 
inflammation was induced in BALB/c mice by intraperitoneal 
injection of ovalbumin in aluminum hydroxide followed 
by challenge with aerosolized ovalbumin, as described in 
the Methods section. Dendritic cells differentiated from 
bone marrow precursors were incubated for 30 minutes at 
37°C with thioperamide (100 µM), an antagonist of H3R/
H4R, or phosphate-buffered saline. Either dendritic cells 
or thioperamide-pretreated dendritic cells were then pulsed 
with ovalbumin 10 µg/mL for three hours at 37ºC and, after 
washing, the cells (5 × 105) were intratracheally injected into 
mice after five days of challenge with aerosolized ovalbumin. 
Control mice were inoculated intratracheally with phosphate-
buffered saline instead of dendritic cells. Figure 1A shows 
the phenotype of the injected dendritic cells. Incubation with 
ovalbumin did not change the maturity status of the dendritic 
cells and, as shown, expression of CD40, CD86, and MHC 
class II was not affected.
Two weeks later, we obtained the population of 
T lymphocytes by treatment of lung cells suspensions with 
a PanT antibody (anti-CD3) and subsequent purification 
through an affinity column. Finally, we analyzed   regulatory 
T   lymphocytes by cytometry. In Figure 1B and C, we found 
as already described19 that injection of immature dendritic 
cells induced an increase in regulatory T cells (CD4+ CD25+ 
FOXP3+) in the lungs of allergic mice. Interestingly, in the 
allergic mice that received dendritic cells with receptors H3 
and H4 blocked by thioperamide, we found high recruitment 
of regulatory T cells in the lungs, which was significantly 
greater than that observed for untreated dendritic cells (40%). 
We noted that while the percentage of CD4+ T lymphocytes 
decreased with both treatments, the population of regulatory 
T cells was even greater, perhaps as a result of inhibition of 
the effector cell population.
It is known that plasmacytoid and lymphoid dendritic 
cells are able to induce T regulatory cells in the lung,20,21 so 
we decided to evaluate whether use of thioperamide affects 
a particular subset of dendritic cells in the lungs of allergic 
mice. Dendritic cells were purified from lung suspensions from 
allergic mice that had been inoculated with ovalbumin-pulsed 
dendritic cells or thioperamide-pretreated dendritic cells, by 
positive selection, using magnetic beads attached to anti-
CD11c. As shown in Figure 2A and B, lymphoid dendritic cells 
(CD11c+ CD8α+) were increased both by dendritic cells and 
thioperamide-pretreated dendritic cells, but no significant dif-
ferences between dendritic cells and thioperamide-pretreated 
dendritic cells were observed, so we can assume that the 
increase was at the expense of dendritic cells alone. Moreover, 
we observed no difference between treatments for the plasma-
cytoid dendritic cell subset   (Figure 2C and D).
Considering that induction of tolerance by dendritic 
cells is associated mainly with release of interleukin-10,22 
we also investigated this issue. As shown in Figure 3A, we 
found that CD11c (+) dendritic cells isolated from the lung 
tissue of mice treated with thioperamide-pretreated dendritic 
cells released higher levels of interleukin-10 compared with 
CD11c (+) cells isolated from the lung tissue of mice that 
received untreated dendritic cells. This result may reflect that 
the blockade of H3/H4 receptors, inhibits the cellular response   
through the induction of regulatory T cells in the lungs of 
allergic mice, could be a mechanism mediated in part, by 
the interleukin-10 secreted from thioperamide-pretreated 
dendritic cells. We investigated this possibility two weeks 
after injection of allergic mice with phosphate-buffered 
saline, dendritic cells, or thioperamide-pretreated dendritic 
cells, by purifying CD11c+ cells from lungs and coculturing 
them with autologous T lymphocytes from allergized mice. 
As shown in Figure 3B, thioperamide-stimulated dendritic 
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cells did not induce proliferation of T cells, and a ratio of 5:1 
(effector:target) strongly inhibited this action.
In order to determine whether H3/H4 receptor blockade 
leads to an improvement in allergy symptoms, we then 
measured serum levels of ovalbumin-IgE antibodies and the 
presence of eosinophils in bronchoalveolar lavage from aller-
gic mice 15 days after intratracheal injection. As shown in 
Figure 4A and B, both of these parameters were significantly 
decreased in allergic mice inoculated with ovalbumin-pulsed 
thioperamide-pretreated dendritic cells compared with the 
allergic controls.
In light of these results, we were interested in investigat-
ing whether these receptors, which are known to be impli-
cated in the allergic process, are represented in the lung tissue 
of allergic mice. Therefore, we analyzed the expression of 
H3R and H4R in mononuclear lung cells of allergic mice by 
confocal microscopy (see Methods section) using positive 
control brain tissue (for H3R) and bone marrow precursors 
(for H4R). We used specific antibodies against these recep-
tors and membrane markers associated with dendritic cells 
and macrophages, such as CD11c and CD11b.23 As shown 
in Figure 5Bi–ii, we found that while expression of H4R was 
associated with cells that express CD11c+ and CD11b+, H3R 
showed only weak expression in the fraction corresponding 
to mononuclear lung cells not associated with expression of 
CD11c and CD11b markers (Figure 5A and Bii).
Discussion
It has been demonstrated in a mouse model of food allergy 
that subcutaneous administration of synthetic peptides com-
prising immunodominant T cell determinants of ovalbumin 
to sensitized BALB/c mice decreases allergy symptoms.24 
This therapy reduced the hypersensitivity reaction, ie, serum 
histamine and ovalbumin-specific IgE levels. Interestingly, 
an increase in mRNA expression of both regulatory mol-
ecules, TGF-β and FOXP3, was detected in intestinal tissues, 
contributing to the suppressive effect to the allergy. In our 
research, we showed in a widely accepted mouse model of 
0
PBS
%
 
C
D
4
+
 
C
D
2
5
+
 
F
O
X
P
3
+
 
c
e
l
l
s
DC DCThi
5
10
*
***
100 101 102
FL1-H
Isotype
103 100 101 102
FL1-H
103 100 101 102
FL1-H
103 100 101 102
FL1-H
103 104
3.8%
R
2
R3
R4 19.31%
R2
R3
R4 13.5%
R2
R3
R4 14.7%
R2
R3
R4 18.8%
R2
4.0% 5.8% 14.8%
Normal PBS DC DCThi
1
0
0
1
0
1
1
0
2
F
L
2
-
H
I
s
o
t
y
p
e
1
0
3
1
0
4
100 101
FL2-H
MHCII CD86 CD40
102
Isotype DC
DCThi
DCOVA
DCThi OVA
103 104
100 101
FL2-H
102 103 104 100 101
FL1-H
102 103 104
0
5
1
0
C
o
u
n
t
s
1
5
2
0
1
0
0
1
0
1
1
0
2
C
D
4
1
0
3
1
0
4
C
D
2
5
Foxp3
A
BC
Figure 1 Thioperamide, a H3R/H4R antagonist acting on dendritic cells, increases the recruitment of Treg lymphocytes in lungs of allergic mice. BALB/c mice were allergized 
as described in the Methods section. Dendritic cells obtained from bone marrow precursors were pretreated or not pretreated with thioperamide 100 µM and pulsed 
with ovalbumin, and were then injected intratracheally (5 × 105 cells/mouse). Control mice were injected with phosphate-buffered saline. (A) Representative histograms of 
the phenotype of dendritic cells injected into allergic mice. After 14 days, we obtained a population of lung lymphocyte cells by treatment of cell suspensions with a PanT 
antibody (anti-CD3) and later purification through an affinity column. The different T cells were analyzed by flow cytometry. (B) Bar graph representing the percentage mean 
of positive cells ± standard error of the mean [n = 4] from three independent experiments. *P # 0.05, ***P # 0.001. Phosphate-buffered saline versus dendritic cells versus 
thioperamide-treated dendritic cells. (C) Representative dot plot.
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Figure 3 Thioperamide induces interleukin-10 production in dendritic cells and inhibition of T lymphocyte proliferation. We obtained a population of lung dendritic cells 
by treatment of cell suspensions with anti-CD11c and later purification through an affinity column. Production of interleukin-10 was analyzed in the supernatants of CD11c+ 
cells (1.5 × 105 cells/200 µL cultured for 18 hours) by enzyme-linked immunosorbent assay. (A) Bar graph representing the arithmetic mean of interleukin-10 concentration 
(pg/mL) ± standard error of the mean, n = 5. *P # 0.05 for phosphate-buffered saline versus dendritic cells versus thioperamide-pretreated dendritic cells. To investigate for 
differences in T lymphocyte stimulatory ability of lung dendritic cells, we purified lung dendritic cells from treated allergic mice after 12 days. Cells were washed and cocultured 
with autologous lymphocytes from allergic mice (5 × 104 dendritic cells/well versus 2.5 × 105 splenocytes/well). Dendritic cells stimulated for 48 hours with lipopolysaccharides 
were included as a positive control. (B) T cell proliferation was measured 72 hours after starting cocultures by [3H]thymidine incorporation. Data are expressed as the mean 
[3H]thymidine incorporation and are representative of five independent experiments. *P , 0.05. (C) Forty-eight hours after starting coculture, the supernatants were collected 
and analyzed for interleukin-10 production by quantitative enzyme-linked immunosorbent assay. 
Note: Mean concentration values are expressed as pg/mL. *P , 0.05.
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acute airway inflammation in response to ovalbumin, that 
intratracheal injection of dendritic cells with H3R/H4R 
blocked by thioperamide increased the   proportions of CD4+ 
CD25+ FOXP3+ cells in the lungs of allergic mice, demon-
strating a role of endogenous histamine in the modulation 
of regulatory T cells. It should be noted that dendritic cells 
constitutively produce histamine,6 although the presence 
of inflammatory stimuli strongly increases the secretory 
capacity of dendritic cells,25 suggesting that histamine could 
play an autocrine role during genesis of the inflammatory 
response.
Functionally, this model is divided in two phases, ie, 
sensitization and provocation.26,27 In the sensitization phase, 
the experimental allergen, ie, ovalbumin, is taken up by 
dendritic cells that induce a polarized Th2 response and 
IgE production. Re-exposure to ovalbumin is referred to as 
provocation that induces the acute allergic reaction. It is now 
widely accepted that recruitment of CD8+ Tc2 cells is crucial 
in maintaining airway hyperresponsiveness and eosinophilia 
in the later phase of the asthma process.28,29 Massive amounts 
of histamine are released in allergic reactions like asthma, 
rhinitis, and conjunctivitis.30 In this sense, the published 
research supports the essential role of this biogenic amine 
in the inflammatory reaction, acting through four histamine 
receptors, referred to as H1R, H2R, H3R, and H4R.31,32
We have previously demonstrated in vitro that histamine 
increases the cross-presentation of soluble ovalbumin by 
immature murine dendritic cells.12 In a recent paper, we also 
showed that histamine acting on dendritic cells can favor 
the recruitment of TCD8+ cells in lung tissue of allergic 
mice, indicating a likely role of this amine in the chronic 
phase.9 This was demonstrated by the fact that mice with 
histamine-treated dendritic cells showed increased levels of 
serum-specific IgE antibodies directed to ovalbumin, and a 
more persistent presence of eosinophils in bronchioalveolar 
lavage fluid compared with mice treated with ovalbumin-
pulsed control dendritic cells. An interesting finding was that 
blocking of H3R/H4R on dendritic cells reduced the numbers 
of eosinophils and specific IgE antibodies in allergic mice, as 
reported by Dunford et al using an H4R-selective antagonist, 
JNJ 7777120 or H4R-deficient mice.25 However, the point of 
balance between dendritic cells and T cells at which symptom 
improvement occurs is not clearly defined. When we analyzed 
regulatory T cells in the lungs of allergic mice, we found 
a greater increase in CD4+/FOXP3+ cells, indicating that 
H4R blockade on dendritic cells with thioperamide caused 
an improvement in asthmatic symptoms by induction of 
T regulatory cells which suppress the effector response via 
production of interleukin-10. It has been shown that activation 
of regulatory T cells in allergy not only leads to suppression of 
lymphocyte proliferation, but also downregulates production 
of specific IgE antibodies and reduces inflammation by inhib-
iting the activity of inflammatory cells, including eosinophils, 
basophils, and mast cells. In addition, the amounts required 
for this function are low, considering that, once specifically 
activated, their suppressor function operates on all effector 
lymphocytes independently of their specificity.33,34
Yang et al showed that increased mRNA expression of 
transforming growth factor beta and FOXP3 in intestinal 
tissues is consistent with low serum histamine levels.24 In 
line with this, our results reinforce the idea that endogenous 
histamine acting on dendritic cells negatively regulates 
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Figure 4 Injection of thioperamide-pretreated dendritic cells into allergic mice decreases serum levels of specific IgE antibodies directed to ovalbumin and infiltration of the 
lungs by eosinophils. Dendritic cells pretreated or not pretreated with histamine and pulsed with ovalbumin were intratracheally inoculated (5 × 105 cells/allergized mouse). 
(A) After 15 days, serum samples were obtained and levels of serum IgE antibodies directed to ovalbumin were determined by enzyme-linked immunosorbent assay using 
serum dilutions of 1/20 and 1/200. Data are expressed as the arithmetic mean of the optical density ± standard error of the mean (n = 6). After 15 and 30 days, amounts 
of eosinophils in bronchoalveolar lavage were determined (B). Data are expressed as the percentage of eosinophils in bronchoalveolar lavage (arithmetic mean ± standard 
error of the mean, n = 6). 
Notes: **P # 0.01, ***P # 0.001 for phosphate-buffered saline versus dendritic cells versus thioperamide-pretreated dendritic cells.
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induction of Treg cells in the lung tissue of allergic mice, 
being dependent on H4R for this action. Morgan et al studied 
a mouse model of airway hypersensitivity and demonstrated 
that intratracheal administration of 4MeHA, an H4R-selective 
ligand, is associated with a reduction in asthma-like symptoms 
attributed to accumulation of FOXP3+ T cells in the lung.35 
These authors assumed an anti-inflammatory function of H4R. 
However, before discovery of H4R, 4MeHA was used as a spe-
cific ligand for H2R, so it is possible that the anti-inflammatory 
effects observed were due to activation of H2R rather than 
H4R.36,37 In rhinitis or conjunctivitis, the H1R antagonist is 
effective in controlling clinical symptoms, but is not relevant 
in asthma. This may be explained by the fact that asthma has 
a multifactorial pathogenesis. In this regard, development of a 
Th2 response is essential for sensitization and the early inflam-
matory response, but the chronicity of the process depends 
on recruitment of CD8+ T cells.29 Our results and those of 
other research groups reinforce the idea that the action of 
histamine on dendritic cells has a proinflammatory role. In 
this way, H4R blockade or deficiency has been effective in 
reducing asthma symptoms in several studies, perhaps through 
an increase in regulatory T cells. Forward et al38 investigated 
the consequences of mast cell and regulatory CD4+ CD25+ 
T cell interaction, and concluded that histamine signaling via 
H1 receptors leads to reduction in the suppressor function of 
these regulatory T cells, and this function is restored when 
histamine levels decrease. Thus, local histamine produced by 
mast cells and dendritic cells could modulate the development 
of inflammatory reactions at different levels, ie, by acting via 
H1R on innate cells present in tissues and by maintenance of 
the inflammatory response via H4R on dendritic cells.
An interesting observation was that expression of the H4 
receptor is restricted to CD11c+ lung cells. Recently, Lundberg 
et al39 showed that blockade of H4R in monocyte-derived 
dendritic cells from allergic donors inhibited allergen-specific 
T cell responses. Given that alveolar macrophages and den-
dritic cells are the most abundant cell populations expressing 
CD11c+ in the lung mucosa,40 and considering that dendritic 
cells are potential targets in allergic therapy because they 
define polarization of T lymphocytes under the influence of 
microenvironment, it is possible that use of H4R antagonists 
may enable more effective treatment of allergic diseases.
Conclusion
We conclude that treatment of dendritic cells with thioperamide, 
an H3/H4 receptor antagonist, increases CD4+ CD25+ FOXP3+ 
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Figure 5 H4R is expressed in mice lung CD11b and CD11c cells. H3R (A) and H4R (Bi) expression was evaluated in mice lung mononuclear cells and in positive controls 
(mice brain and bone marrow) by confocal microscopy. Specific antibodies were used against H3R and H4R (conjugated with fluorescein isothiocyanate, green) and CD11b 
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regulatory T cells in the lungs of allergic mice, suggesting that 
endogenous histamine exerts autocrine control of dendritic cells 
during the inflammatory response. Considering that mucosal 
dendritic cells in the lung express the H4 receptor, we believe 
that its blockade may favor the induction of a beneficial anti-
inflammatory response to counteract allergic effects.
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